loading
Lexaria Bioscience Corp stock is traded at $0.897, with a volume of 170.12K. It is up +4.72% in the last 24 hours and down -24.61% over the past month. Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
See More
Previous Close:
$0.8567
Open:
$0.83
24h Volume:
170.12K
Relative Volume:
0.40
Market Cap:
$17.55M
Revenue:
$411.00K
Net Income/Loss:
$-4.85M
P/E Ratio:
-2.0386
EPS:
-0.44
Net Cash Flow:
$-4.88M
1W Performance:
+6.80%
1M Performance:
-24.61%
6M Performance:
-33.55%
1Y Performance:
-71.06%
1-Day Range:
Value
$0.83
$0.8999
1-Week Range:
Value
$0.8019
$0.99
52-Week Range:
Value
$0.7749
$3.15

Lexaria Bioscience Corp Stock (LEXX) Company Profile

Name
Name
Lexaria Bioscience Corp
Name
Phone
250-765-6424
Name
Address
100 - 740 MCCURDY ROAD, KELOWNA
Name
Employee
7
Name
Twitter
Name
Next Earnings Date
2025-07-28
Name
Latest SEC Filings
Name
LEXX's Discussions on Twitter

Compare LEXX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
LEXX
Lexaria Bioscience Corp
0.8971 19.04M 411.00K -4.85M -4.88M -0.44
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.08 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
472.17 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
551.77 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
809.14 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
331.09 35.16B 4.56B -176.77M 225.30M -1.7177

Lexaria Bioscience Corp Stock (LEXX) Latest News

pulisher
09:32 AM

What catalysts could drive Lexaria Bioscience Corp. stock higher2025 Volatility Report & Smart Allocation Stock Tips - newser.com

09:32 AM
pulisher
09:06 AM

Is Lexaria Bioscience Corp. Equity Warrant stock in correction or buying zone2025 Pullback Review & AI Forecasted Entry/Exit Points - newser.com

09:06 AM
pulisher
08:42 AM

Combining machine learning predictions for Lexaria Bioscience Corp. Equity WarrantJuly 2025 WrapUp & Expert Curated Trade Setup Alerts - newser.com

08:42 AM
pulisher
03:54 AM

How Lexaria Bioscience Corp. stock performs in rising dollar environmentEarnings Overview Summary & AI Enhanced Trade Execution Alerts - newser.com

03:54 AM
pulisher
12:10 PM

Is Lexaria Bioscience Corp. stock ready for a breakoutAnalyst Upgrade & Low Drawdown Investment Strategies - newser.com

12:10 PM
pulisher
Oct 12, 2025

Will Lexaria Bioscience Corp. Equity Warrant outperform the marketTrade Risk Summary & Technical Buy Zone Confirmations - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Earnings visualization tools for Lexaria Bioscience Corp. Equity Warrant2025 Valuation Update & Safe Capital Growth Tips - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Can trapped investors hope for a rebound in Lexaria Bioscience Corp. Equity WarrantTrade Risk Assessment & Precise Trade Entry Recommendations - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Can Lexaria Bioscience Corp. hit a new high this monthMarket Risk Analysis & Smart Allocation Stock Reports - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Lexaria expands pharmaceutical outreach with new advisory firm By Investing.com - Investing.com Nigeria

Oct 09, 2025
pulisher
Oct 09, 2025

Lexaria Bioscience Corp. Provides Strategic Update - NewMediaWire

Oct 09, 2025
pulisher
Oct 09, 2025

Lexaria Bioscience Expands Strategic Outreach and Secures New Patents - TipRanks

Oct 09, 2025
pulisher
Oct 09, 2025

Lexaria (LEXX) Expands R&D Efforts with Enhanced Funding and New Partnerships - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

Lexaria expands pharmaceutical outreach with new advisory firm - Investing.com India

Oct 09, 2025
pulisher
Oct 09, 2025

$4.0M Financing backs Lexaria's global BD push; 4 new patents bolster DehydraTECH R&D into 2026 - Stock Titan

Oct 09, 2025
pulisher
Oct 09, 2025

Can trapped investors hope for a rebound in Lexaria Bioscience Corp.2025 Major Catalysts & Community Verified Swing Trade Signals - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Historical volatility pattern of Lexaria Bioscience Corp. visualized2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Custom watchlist performance reports with Lexaria Bioscience Corp.2025 Major Catalysts & Pattern Based Trade Signal System - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

News impact scoring models applied to Lexaria Bioscience Corp. Equity WarrantMarket Sentiment Report & Real-Time Volume Analysis - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Can swing trading help recover from Lexaria Bioscience Corp. Equity Warrant losses2025 Key Lessons & Weekly Top Gainers Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Lexaria Bioscience Corp Stock Analysis and ForecastAutomated Trading Signals & Explosive Capital Growth - earlytimes.in

Oct 08, 2025
pulisher
Oct 06, 2025

Will Lexaria Bioscience Corp. see short term momentumMarket Sentiment Report & Fast Entry High Yield Stock Tips - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Lexaria Bioscience Corp. Equity Warrant stock daily chart insightsWeekly Risk Report & High Conviction Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Real time social sentiment graph for Lexaria Bioscience Corp.Quarterly Trade Review & Technical Pattern Based Buy Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Smart tools for monitoring Lexaria Bioscience Corp.’s price actionWeekly Market Outlook & Weekly Stock Performance Updates - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Can Lexaria Bioscience Corp. Equity Warrant stock deliver surprise earnings beatCPI Data & Fast Moving Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

When is the best time to exit Lexaria Bioscience Corp.Entry Point & Community Verified Trade Signals - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Lexaria Bioscience Corp. stock reversal real or fakeAnalyst Downgrade & Reliable Price Action Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What drives Lexaria Bioscience Corp stock priceFundamental Stock Analysis & High Yield Trading Plans - earlytimes.in

Oct 03, 2025
pulisher
Oct 03, 2025

Lexaria Bioscience Corp. Equity Warrant stock trendline breakdownWeekly Stock Summary & Accurate Buy Signal Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What’s next for Lexaria Bioscience Corp. Equity Warrant stock price2025 Price Action Summary & Breakout Confirmation Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Chart based exit strategy for Lexaria Bioscience Corp. Equity WarrantJuly 2025 Momentum & Free High Return Stock Watch Alerts - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Will earnings trigger a reversal in Lexaria Bioscience Corp.2025 Stock Rankings & Reliable Trade Execution Plans - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

LEXX: Biodistribution Study Results - Yahoo Finance

Oct 02, 2025
pulisher
Oct 01, 2025

Lexaria Bioscience announces ~$4M registered direct offering of shares - MSN

Oct 01, 2025
pulisher
Sep 30, 2025

Lexaria Bioscience Ends Capital on Demand Agreement - MSN

Sep 30, 2025

Lexaria Bioscience Corp Stock (LEXX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Lexaria Bioscience Corp Stock (LEXX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
BUNKA CHRISTOPHER
Director
Jul 30 '25
Buy
0.91
11,900
10,866
281,912
McKechnie William Edward
Director
Jul 29 '25
Buy
0.91
5,000
4,532
18,191
DOCHERTY JOHN MARTIN
President & CSO
Jul 29 '25
Buy
0.93
5,376
4,989
5,376
Carle Vanessa
Secretary
Jul 29 '25
Buy
0.91
750
682
750
CHRISTOPHER RICHARD
Chief Executive Officer
Jul 29 '25
Buy
0.91
15,000
13,641
65,000
CHRISTOPHER RICHARD
Chief Executive Officer
Dec 03 '24
Buy
2.47
27,172
67,175
50,000
CHRISTOPHER RICHARD
Chief Executive Officer
Dec 02 '24
Buy
2.24
22,828
51,217
22,828
$84.60
price up icon 0.95%
$22.86
price up icon 6.98%
$32.48
price up icon 2.23%
$102.55
price up icon 0.63%
$165.94
price up icon 2.27%
biotechnology ONC
$330.74
price up icon 3.34%
Cap:     |  Volume (24h):